Reply

We were encouraged to learn that frontline clinicians agree with our study findings and share our concern about an increased risk of neuropsychiatric events (NPSEs) in children with asthma who are prescribed montelukast. Dr Kovesi suggests that our results may even underestimate that risk.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Letters to the Editor Source Type: research